HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Straighten the cleaning solution Pour it into the cleaning position for cleaning Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes,ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
Saline Solution is intended for use in OTC ear,nose,and throat devices intended specifically to administer medicinal substances to treat ear,nose,and throat disorders.These instruments include the powder blower,dropper,ear wick,manual nebulizer pump,and nasal inhaler. If using with an OTC ear,nose,or throat device,the follow the directions provided with the device and only use as directed.
HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes, ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The pH ranges from 4.5 to 7.0. Composition, osmolarity, and ionic concentration are shown below: 0.9% Sodium Chloride Injection, USP contains 9 g/L Sodium Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (calc). It contains 154 mEq/L sodium and 154 mEq/L chloride. The FLEBOFLEX and FLEBOFLEX LUER plastic containers are fabricated from latex-free polyolefins or polypropylene plastic materials. The solution contact materials do not contain PVC, DEHP, or other plasticizers. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. The suitability of the container materials has been established through biological evaluations, which have shown the containers pass Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container systems.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
0.9% Sodium Chloride Injection, USP solution is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1,000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solution is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for injection, USP is chemically designated H2O. The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (freeflex® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each mL contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 5.3 (4.5 to 7.0). Sodium Chloride, USP is chemically designated NaCl, a white crystalline compound freely soluble in water. The glass container is a Type I borosilicate glass and meets the requirements of the powdered glass test according to the USP standards. The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration.
1000 Roses CC Color plus Correct Sheer Beige SPF 30ZINC OXIDE
Uses Helps prevent sunburn. If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
100% Mineral Broad Spectrum Sunscreen SPF 30TITANIUM DIOXIDE ZINC OXIDE
Uses Helps prevent sunburn. If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early aging caused by the sun.
Uses Helps prevent sunburn If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early aging caused by the sun.
12 CELL SALTS COMPLEXCALCAREA FLUORICA CALCAREA PHOSPHORICA CALCAREA SULPHURICA FERRUM PHOSPHORICUM KALI MURIATICUM KALI PHOSPHORICUM KALI SULPHURICUM MAGNESIA PHOSPHORICA NATRUM MURIATICUM NATRUM PHOSPHORICUM NATRUM SULPHURICUM SILICEA
HOMEOPATHIC INDICATIONS: For the temporary relief of symptoms related to headache, joint pain, swollen glands, sweating, congestion, low blood pressure, and fatigue.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Brain Balance Core Formula Acetylcholine chloride, Dopamine hydrochloride, GABA (Gamma-aminobutyric acid), Octopamine, Serotonin (Hydrochloride), Taurine, ACETYLCHOLINE CHLORIDE ACETYLCHOLINE DOPAMINE HYDROCHLORIDE DOPAMINE .GAMMA.-AMINOBUTYRIC ACID .GAMMA.-AMINOBUTYRIC ACID OCTOPAMINE OCTOPAMINE SEROTONIN HYDROCHLORIDE SEROTONIN TAURINE TAURINE ADENOSINE CYCLIC PHOSPHATE ADENOSINE CYCLIC PHOSPHATE SUS SCROFA CEREBRUM SUS SCROFA CEREBRUM SUS SCROFA DIENCEPHALON SUS SCROFA DIENCEPHALON SUS SCROFA PINEAL GLAND SUS SCROFA PINEAL GLAND SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS WATER ALCOHOL
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms including difficulty sleeping or concentrating, loss of appetite, irritability, feelings of hopelessness and self-loathing.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
HOMEOPATHIC INDICATIONS: For the temporary relief of aches, pains, and swelling in bones, teeth, and joints.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
INDICATIONS: For temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue, and detoxification stress.
Lymphoplex Myrrha, Trigonella Foenum Graecum, Pinus Sylvestris, Lymph, Spleen, Conium Maculatum, Echinacea, Hepar Sulphuris Calcareum, Hydrangea Arborescens, Phytolacca Decandra, Silicea MYRRH MYRRH FENUGREEK SEED FENUGREEK SEED PINUS SYLVESTRIS LEAFY TWIG PINUS SYLVESTRIS LEAFY TWIG SUS SCROFA LYMPH SUS SCROFA LYMPH SUS SCROFA SPLEEN SUS SCROFA SPLEEN CONIUM MACULATUM FLOWERING TOP CONIUM MACULATUM FLOWERING TOP ECHINACEA, UNSPECIFIED ECHINACEA, UNSPECIFIED CALCIUM SULFIDE CALCIUM SULFIDE HYDRANGEA ARBORESCENS ROOT HYDRANGEA ARBORESCENS ROOT PHYTOLACCA AMERICANA ROOT PHYTOLACCA AMERICANA ROOT SILICON DIOXIDE COLLOIDAL SILICON DIOXIDE WATER ALCOHOL
INDICATIONS: Temporary relief of symptoms related to blocked energy in the region of the mid abdomen including indigestion, fatigue, bloating, cramping and abdominal anxiety.
Octopamine Octopamine OCTOPAMINE OCTOPAMINE WATER ALCOHOL
INDICATIONS: For the temporary relief of symptoms of chronic illness including fatigue, effects of toxin buildup, slowed metabolism, and weakened constitution.
HGH Vitality Agnus Castus, Ambra Grisea, Conium Maculatum, Apiolum, Estradiol, Estriol, Folliculinum, L Dopa, Melatonin, Testosterone, Alpha-Lipoicum Acidum, ATP, Coenzyme A, Coq10, Nadidum, Sarcolacticum Acidum, Baryta Carbonica, Selenium Metallicum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus (Suis), Lymph (Suis) Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone, Morgan Pure CHASTE TREE CHASTE TREE AMBERGRIS AMBERGRIS CONIUM MACULATUM FLOWERING TOP CONIUM MACULATUM FLOWERING TOP APIOLE (PARSLEY) APIOLE (PARSLEY) ESTRADIOL ESTRADIOL ESTRIOL ESTRIOL ESTRONE ESTRONE LEVODOPA LEVODOPA MELATONIN MELATONIN TESTOSTERONE TESTOSTERONE .ALPHA.-LIPOIC ACID .ALPHA.-LIPOIC ACID ADENOSINE TRIPHOSPHATE ADENOSINE TRIPHOSPHATE COENZYME A COENZYME A UBIDECARENONE UBIDECARENONE NADIDE NADIDE LACTIC ACID, L- LACTIC ACID, L- BARIUM CARBONATE BARIUM CATION SELENIUM SELENIUM SUS SCROFA UMBILICAL CORD SUS SCROFA UMBILICAL CORD SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND PORK LIVER PORK LIVER SUS SCROFA HYPOTHALAMUS SUS SCROFA HYPOTHALAMUS SUS SCROFA LYMPH SUS SCROFA LYMPH SUS SCROFA BONE MARROW SUS SCROFA BONE MARROW SUS SCROFA OVARY SUS SCROFA OVARY SUS SCROFA TESTICLE SUS SCROFA TESTICLE SUS SCROFA PANCREAS SUS SCROFA PANCREAS SUS SCROFA SPLEEN SUS SCROFA SPLEEN SOMATROPIN SOMATROPIN PROTEUS MORGANII PROTEUS MORGANII WATER ALCOHOL
INDICATIONS AND USAGE For temporary relief of symptoms related to aging including deterioration of muscles, joints and skin, sexual dysfunction, memory loss and fatigue.
INDICATIONS AND USAGE For temporary relief of minor symptoms of sore, overexerted muscles.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.